Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies
- 21 July 2020
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 220, 110-114
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS113828)
- Mayo Clinic
- National Institutes of Health (R01NS113828)
This publication has 24 references indexed in Scilit:
- MOG cell-based assay detects non-MS patients with inflammatory neurologic diseaseNeurology Neuroimmunology & Neuroinflammation, 2015
- Evaluation of aquaporin‐4 antibody assaysClinical and Experimental Neuroimmunology, 2014
- History of the Rochester Epidemiology Project: Half a Century of Medical Records Linkage in a US PopulationMayo Clinic Proceedings, 2012
- Serologic diagnosis of NMONeurology, 2012
- Use of a Medical Records Linkage System to Enumerate a Dynamic Population Over Time: The Rochester Epidemiology ProjectAmerican Journal of Epidemiology, 2011
- Multiple Sclerosis Risk After Optic NeuritisArchives of Neurology, 2008
- Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNature Medicine, 2007
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- History of the Rochester Epidemiology ProjectMayo Clinic Proceedings, 1996
- Optic neuritisNeurology, 1995